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Abstract 
Sterols are essential lipids, involved in many biological processes. In Saccharomyces cerevisiae, the en-
zymes of the ergosterol biosynthetic pathway (Erg proteins) are localised in different cellular compartments. 
With the aim of studying organelle interactions, we discovered that Erg27p resides mainly in Lipid Droplets 
(LDs) in respiratory competent cells, while in absence of respiration, is found mostly in the ER. The results 
presented in this paper demonstrate an interplay between the mitochondrial respiration and ergosterol pro-
duction: on the one hand, rho° cells show lower ergosterol content when compared with wild type respiratory 
competent cells, on the other hand, the ergosterol biosynthetic pathway influences the mitochondrial status, 
since treatment with ketoconazole, which blocks the ergosterol pathway, or the absence of the ERG27 gene, 
induced rho° production in S. cerevisiae. The loss of mitochondrial DNA in the ∆erg27 strain is fully sup-
pressed by exogenous addition of ergosterol. These data suggest the notion that ergosterol is essential for 
maintaining the mitochondrial DNA attached to the inner mitochondrial membrane. 
 
 
 
Keywords: ergosterol, mitochondria, rho° cells, S. cerevisiae, lipid droplets, sterols.  
Abbreviation: ER, Endoplasmic Reticulum; LDs, Lipid Droplets; mt, mitochondria; wt, wild type. 
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1. Introduction  
Sterols are essential lipid components which control fluidity and permeability of membranes [1]. The choles-
terol content is tightly regulated, minor changes in its amount has an impact on cellular functions [2]. In 
mammalian cells, cholesterol is the principal sterol, also used as a precursor of steroids and bile acids. Disor-
ders in cholesterol metabolism lead to human diseases, including neurodegeneration [3, 4]. 
The yeast S. cerevisiae synthesizes ergosterol through a complex pathway of more than twenty reactions [5-
7] catalysed by enzymes (Erg proteins) located in different cellular compartments: cytoplasm, endoplasmic 
reticulum (ER) and Lipid Droplets (LDs) (Figure 1). The ergosterol biosynthetic pathway is conserved in 
evolution and seventeen out of nineteen tested genes were replaceable by the human counterpart [8]. 
In S. cerevisiae, ergosterol is an essential component of all cellular membranes, including organelle mem-
branes. The mitochondrial concentration of ergosterol is different between the inner mitochondrial mem-
brane (IMM) and in outer mitochondrial membrane (OMM). Of note, the IMM is more enriched in 
ergosterol than the OMM (6μg ergosterol per mg of organellar protein in the outer membrane and 25μg/mg 
in the inner membrane) [9, 10]. Ergosterol is actively transported into the OMM in an energy independent 
way [11, 12]. Mitochondria have an essential role in lipid metabolism and communicate with other orga-
nelles such as Endoplasmic Reticulum (ER), Lipid Droplets (LDs) and peroxisomes [13-17]. In yeast, the 
ER–Mitochondrial Encounter Structure (ERMES) complex (Mdm34p, Mmm1p, Mdm12p and Mdm10p) 
tethers ER and mitochondria. This complex is an important “ hub” because the ER-mitochondria contact 
sites are involved in phospholipid exchange, mitochondrial division, distribution and morphology and 
maintenance of mitochondrial DNA [18, 19]. This complex is not conserved in metazoan but its essential 
functions are assured by different complexes and recently the human homologue of Mmm1p has been identi-
fied [20-24]. While phospholipid biogenesis has been extensively investigated at the contact site between ER 
and mitochondria, less is known about ergosterol function in yeast mitochondria [25, 26]. It is also unclear 
whether ergosterol transport to mitochondria is facilitated by direct membrane contacts, either between ER 
and mitochondria or between Lipid Droplets and mitochondria [11]. It has been observed that yeast cells 
lacking the ERMES complex have altered level of ergosterol, pointing to a role of the ER-mitochondrial con-
tact site for sterol exchange [27]. Indeed, ERG24, ERG28 and ERG6 genes were isolated in a screening for 
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mutants defective in mitochondrial distribution and morphology [28] and mitochondrial morphogenesis and 
inheritance rely on the presence of the ergosterol biosynthetic enzymes since transcriptional down regulation 
of the ergosterol genes results in mitochondrial membrane alteration [29]. 
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Figure 1. Localisation of the yeast ergosterol biosynthetic pathway enzymes (ERG) in cytoplasm, Endoplas-
mic Reticulum (ER) and Lipid Droplets (LDs). The enzymes of this pathway are essential for life till 
Erg25p-26p-27p complex. 
 
We sought to investigate the relationship between mitochondria and LDs and we discovered that, on the one 
hand, in yeast cells lacking mitochondrial DNA or with a block of respiration (dysfunctional mitochondria), 
the Erg27p enzyme moves from LDs to ER and the ergosterol content is low in these cells; on the other 
hand, the block of the ergosterol biosynthetic pathway with ketoconazole leads to the loss of mitochondrial 
DNA (rho° cells), and the yeast strain deleted for ERG27 gene shows high petites production (cells devoid of 
mitochondrial DNA), a phenotype which is suppressed by adding ergosterol in the medium culture. These 
results suggest a cross talk between mitochondria and the ergosterol biosynthetic pathway, demonstrating the 
essential function of ergosterol in the maintenance of mitochondrial DNA in yeast cells. 
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2. Material and Methods 
2.1 Yeast strains and growth conditions 
The strains used in this study were derived from W303 (MAT a, his3-11, ade2-1, leu2-3, -112, ura3-1, trp1-
1, can1-100) or BY4741 genetic context (MAT a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0). The strains used in this 
study were generated by mating, sporulation and tetrad dissection. The ∆erg27 genotype is: MATa, upc2-1, 
hap1Ty, ura3, his3, leu2, trp1, erg27::LEU2; the ∆mdm34 genotype is MAT a, his3-11, ade2-1, leu2-3,-
112, ura3-1, trp1-1, can1-100, mdm34::URA3. The ∆rtg2 genotype is: MAT , his3-11, ade2-1, leu2-3, -
112, ura3-1, trp1-1, can1-100, rtg2::LEU2. To verify the percentage of petites production of a strain con-
taining only the upc2-1 mutation, we used the ∆erg27 strain transformed with a plasmid expressing the wild 
type ERG27 gene (pST10(ERG27)) [30]. The plasmid pVT100U-mitoGFP was used to visualize mitochon-
dria [31]. 
 
Yeast culture media: YPD (1% bacto peptone, 1% yeast extract and 2% glucose), was used as rich medium. 
YPG (1% bacto peptone, 1% yeast extract and 3% glycerol), was the medium used to verify the respiratory 
competence of yeast colonies. W0 (0.17% yeast nitrogen base, 0.5% ammonium sulphate and 2% glucose) 
was used as minimal medium. All media were supplemented with 2.3% bacto agar (Difco) for solid media 
and W0 was supplemented with the appropriate nucleotides requirements according to the phenotype of the 
strains. The ∆erg27 strain is grown in YPD medium supplemented with 0.02mg/ml of ergosterol. Ergosterol 
and Tween 80 were dissolved in pure ethanol to final concentration of 10 mg/ml for ergosterol and 42% for 
Tween 80, and steamed at 100°C for 10 minutes, always protected from light, before being added to the me-
dium [32, 33]. 
Yeast cultures were grown and analyzed in exponential phase at 28°C, unless otherwise specified. 
2.2 Rho° production 
Strains (W303 or BY4741 genetic context) devoid of mitochondrial DNA were produced as follows: cells 
were grown at the density of 1x10
6
cells/ml on YPD medium, phosphate buffer pH 6.5 was added in 1 ml of 
culture, at the final concentration of 0.05M, and ethidium bromide at final concentration of 50 μg/ml. The 
cultures were incubated at 28°C for 24h. Cells were washed twice, plated on YPD and incubated at 28°C. 
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The absence of mitochondrial DNA was assessed by DAPI staining and absence of growth on glycerol con-
taining medium as a carbon source. 
2.3 Petites assay 
Cells were grown in YPD (supplemented with 0.02mg/ml ergosterol for the ∆erg27) until the stationary 
phase. From these cultures, cells were inoculated in YPD supplemented with 0.02mg/ml ergosterol. At the 
concentration of 1x10
7
cells/ml and 1x10
8
cells/ml, 100 cells were spotted in YPD plates and incubated at 
28°C. After two days, colonies were replicated on YPG plates. Cells grew only on YPD and not on YPG 
plates are petites, DAPI staining was performed to verify the complete absence of mtDNA (rho° cells). 
2.4 Microscopy 
Cells were observed with a Zeiss Axio Imager Z1 Fluorescence Microscope with AxioVision 4.8 Digital Im-
age Processing System, the objective lens used was 63x Oil (Figure 2, 3, 7, 9 and Supplemental Figure 1) 
[34].  Filter sets: 38HE (GFP), 43HE (DsRed). Filters for GFP (470/40 nm excitation and 525/50 nm emis-
sion), and RFP (550/25 nm excitation and 605/70 nm emission) were used. Better selectivity for cytoplas-
mic Lipid Droplets was obtained when the cells were viewed for yellow-gold fluorescence (excitation, 450-
500 nm; emission, greater than 528 nm) rather than red fluorescence (excitation, 515-560 nm; emission, 
greater than 590 nm): for this reason, Nile Red was observed with GFP filter [35]. Metamorph software 
(Universal Imaging, West Chester, PA) was used to deconvolute Z-series and treat the images. 
2.5 Nystatin and Ketoconazole assay 
Cells were grown to a density of 1x10
7
 cells /ml in YPD rich medium supplemented with different Nystatin 
and Ketoconazole (Sigma Aldrich) concentration and a total of 100 cells were plated on YPD plates incubat-
ed at 28°C for two days [36]. Colonies were counted and counts plotted into a graph. 
2.6 Mass spectrometric analysis 
Dry cell pellets were deep frozen by immersion in liquid nitrogen and quickly ground to a powder using an 
IKA A11 basic laboratory mill (IKA, Staufen, Germany). 300 mg of cell pellet were transferred to glass vials 
with 10ml Folch solvent (chloroform/methanol 2:1, v/v) containing 0.01% butylated hydroxytoluene fol-
lowed by the addition of 10 µl of internal standard (19-hydroxy-cholesterol, 2 mg/ml in methanol) as internal 
standards (IS). The homogenization and extraction (60 min) were carried out at room temperature (RT). The 
extracts were evaporated under a stream of N2 then the dry residue was dissolved in 1ml hydrolysis solution 
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containing 5% KOH in (MeOH/H2O, 95:5) and subjected to saponification (1h, 80°C). The hydrolysed solu-
tion was extracted with 0.5ml distilled H2O and 4ml diethyl ether. The ether phase was dried under a stream 
of N2 at RT. The samples were then reconstituted with 25µl ethylacetate and vortex mixed. The fractions to 
be analysed were converted to their trimethyl-silylated derivatives by heating with 40µl BSTFA containing 
1% TMCS at 70°C for 45 min. The sample was dried under a stream of N2.  The residue was dissolved in 
200ml hexane and the clear hexane phase was transferred into a glass vial for GC–MS injection. GC-MS 
analyses were performed with an Agilent 6850A gas chromatograph coupled to a 5973N quadrupole mass 
selective detector (Agilent Technologies, Palo Alto, CA, USA). Chromatographic separations were carried 
out with an Agilent HP5ms fused-silica capillary column (30m × 0.25mm i.d.) coated with 5%- phenyl-95%-
dimethylpolysiloxane (film thickness 0.25μm) as stationary phase. Injection mode: splitless at a temperature 
of 280°C. Column temperature program: 120°C (1min) then to 320°C at a rate of 5°C/min and held for 5 
min. The carrier gas was helium at a constant flow of 1.0ml/min. The spectra were obtained in the electron 
impact mode at 70eV ionization energy; ion source 280°C; ion source vacuum 10-5Torr. MS analysis was 
performed simultaneously in TIC (mass range scan from m/z 50 to 800 at a rate of 0.42 scans s-1) and SIM 
mode. For GC-SIM-MS analysis, ion m/z 363 was selected for ergosterol and ion m/z 353 was selected for 
the internal standard. 
2.7 Real Time RT-PCR 
1 μg of total RNA extracted from cell cultures was reverse transcribed using 200ng of 16mers oligo dT (Life 
technologies) with SuperScript III First-Strand Synthesis System for RT-PCR (Life technologies), according 
to the manufacturer's instructions. cDNA served as template for subsequent Real Time PCR reactions that 
were set up in duplicate for each sample using the SensiMix SYBR Mix (Bioline, London, United Kingdom) 
and an Applied Biosystems Prism 7300 Sequence Detector. The reaction mixtures were kept at 95°C for 10 
min, followed by 40 cycles at 95°C for 15 sec and 60°C for 1 min. The threshold cycle (Ct) was calculated 
using the Sequence Detector Systems version 1.2.2 (Life technologies) by determining the cycle number at 
which the change in the fluorescence of the reporter dye (ΔRn) crossed the threshold. To synchronize each 
experiment, the baseline was set automatically by the software. Relative quantification was carried out with 
the 2
-ΔΔCt
 method, using the abundance of Actin transcript as endogenous house-keeping control. Data were 
statistically analyzed by Student’s t-test. 
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2.8 Western blot  
10 ml of cells grown to 1×10
7
 cell/ml are extracted by performing trichloroacedic acid (TCA) protein precip-
itation. Proteins are resolved on 10% Tris–glycine PAGE, transferred to PVDF membranes and 
immunoblotted using the a-Gfpp antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and a-Ada2p anti-
body (Santa Cruz Biotechnology, Santa Cruz, CA). The secondary antibody was anti-Goat (Santa Cruz Bio-
technology) and anti-Rabbit (Santa Cruz Biotechnology). The proteins were visualized utilizing the Bio 
Rad’s ChemiDoc XRS+system, according to manufacturer’s instructions. Erg27p-GFP bands were quanti-
fied with Image Lab 5.1 version software by Bio Rad. 
2.9 Incorporation of [
14
C] acetate into non-saponifiable lipids of yeast cells 
Sterol biosynthesis in whole yeast cells was followed by incorporation of [
14
C] acetate into non-saponifiable 
lipids as described previously [30]. Briefly, washed cells (1×10
8
 cells) were resuspended in 1ml of fresh me-
dia, incubated with 0.1 μCi of [14C]acetate ([1,2-14C]acetate (50 μCi, 1.85 MBq) from Perkin-Elmer, Italy) in 
presence of Tween-80 (0.2 mg/ml) and shaken for 3 h at 30°C. Cells were then saponified in 1ml of 
methanolic KOH (15% w/v) for 30 min at 80°C. Non-saponifiable lipids were extracted with petroleum ether 
and separated on TLC plates (20×20 cm×0.25 mm) using cyclohexane/ethyl acetate (85:15; v/v). Squalene, 
oxidosqualene, dioxidosqualene, lanosterol, ketosteroid 1 (a mixture of 4-methylzymosterone and 4-
methylfecosterone), ketosteroid 2 (a mixture of zymosterone and episterone) and ergosterol were used as ref-
erences. Radioactivity in separated bands was measured by collecting counts over a 5 min period with a Sys-
tem 200 Imaging Scanner (Hewlett- Packard, Palo Alto, CA, USA). 
2.10 Vitality - Standard Plate Count (SPC) 
Cells were grown in exponential phase in YPD rich medium supplemented with nystatin or ketoconazole 
(Sigma Aldrich). After 24 hours cells were counted with the Bürker chamber and diluted with sterile deion-
ized water to spread 100 cells in each YPD plate (five independent experiments). The plates were incubated 
at 28°C for 48 hours and individual colonies we counted to calculate the percentage of viability [37]. The 
same experiment was performed at  48, 72, and 96 hours.  
3. Results 
3.1 Erg27p mostly resides in ER in rho° cells 
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An interactomic study between LDs and mitochondria showed that Erg6p (LDs resident protein) physically 
interacts with mitochondrial outer membrane proteins [38]. We were interested to investigate LDs-
mitochondrial interactions in a ERMES defective strain; to this purpose, we used a strain deleted for the 
MDM34 gene containing the ERG27-GFP fusion in the ERG27 locus, to visualize the localization of the pro-
tein by fluorescence microscopy (see Materials and Methods). We chose to investigate the Erg27p because it 
is essential and mainly LD localized. The Erg27p fused to GFP is fully functional [39]. As a control, we 
used a W303-ERG27-GFP devoid of mitochondrial DNA (rho°) because ∆mdm34 (previously named 
∆mmm2) is a rho° respiratory impaired strain [40]; the reason why ∆mdm34 is devoid of mitochondrial DNA 
is because this protein is part of the ERMES complex, crucial in coordinating mitochondrial DNA division 
and replication [41, 42]. As expected, in a wild-type strain Erg27p-GFP was mainly located in LDs [43]. 
Surprisingly, in ∆mdm34 and in wild-type rho° strain, used as a control, the Erg27p-GFP mainly decorated 
nuclear and cortical ER, Figure 2A (we obtained the same result also with strains deleted for the other 
ERMES subunits, not shown). Since Erg2p-GFP is localized in the ER also in the wild-type rho° control 
strain, the Erg27p delocalization was presumably not due to the absence of a functional ERMES complex it-
self, but rather to the lack of mtDNA. We then decided to investigate if the Erg27p localization in nuclear 
and cortical ER in rho° cells could have a physiological significance. It was previously observed that in a 
yeast mutant devoid of LDs, some enzymes of the ergosterol biosynthesis, usually positioned in LDs, were 
retained in the ER [44]. We therefore tested the presence of LDs in W303 and W303 rho° cells by using Nile 
Red staining. Figure 2B shows that the LDs were present, indicating that the ER location of Erg27p in a rho° 
strain was not due to a major alteration of LDs biogenesis; of note, we observed a lower amount of LDs in 
W303 rho° and in ∆mdm34. Figure 2C shows the percentage of cells in which Erg27p is exclusively present 
in LDs or in ER or in LDs and in ER in the same cell. 
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Figure 2. The Erg27-GFP protein is mainly ER localised in strains devoid of mtDNA (rho° cells). (A) 
Erg27p-GFP localization in W303, W303 rho° and ∆mdm34 strains in exponential growth phase in YPD. (B) 
Lipid Droplets visualization with Nile Red. Bar: 2µm. The magnification is the same in each picture of Fig-
ure 2. (C) Quantitative analysis of Erg27-GFPp localization. Erg27p in LDs means that Erg27p is visualized 
in a cell only in LDs. Erg27p in ER means that Erg27p is visualized in a cell only in ER, and Erg27p in 
LDs+ER means that Erg27p is visualized in a cell both in LDs and ER. (Data are the average of four inde-
pendent experiments and standard deviation is indicated). 
 
3.2 Transfer of Erg27p from LDs to ER after treatment with antimycin A 
To explore the dynamics of Erg27p localization in cell compartments still containing mitochondrial DNA but 
with an impairment of mitochondrial function, W303 wild-type cells were treated with antimycin A. This 
drug rapidly acts on yeast cells blocking the cytochrome c reductase on the respiratory chain [45]; Erg27p-
GFP was visualized by microscopy from t=0 till 1 hour after addition of 10 g/ml (final concentration) of 
antimycin A. At 3 minutes from antimycin addition, Erg27p-GFP was found to have moved in the ER (Fig-
ure 3A). As a control, we visualized Erg6p, which is mainly located in LDs; after 10 minutes, in the wild 
type strain W303-ERG6-RFP treated with antimycin A, Erg6p was not relocalized (Figure 3B). 
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Figure 3. Antimycin A induces a Erg27p relocalization from LDs to ER. (A): in wild type W303 cells treated 
with antimycin (10µg/ml), Erg27p-GFP relocalized in nuclear and cortical ER in 3 minutes. (B): Erg6p-RFP 
a LDs resident enzyme, is correctly localized in LDs wild type strain after antimycin treatment. Bar: 2µm. 
The magnification is the same in each picture. 
 
We observed the cells till one hour after the treatment and, while Erg27p was still located at the ER, Erg6p 
was still visible in LDs (data not shown). These experiments indicated that the block of the respiratory chain 
and localization of Erg27p in the ER were strongly correlated and that relocalization was not due to an indi-
rect effect in rho° cells. 
To verify the specificity of ER positioning of Erg27p in rho° cells, we investigated the location of Erg7p, us-
ing a rho° ERG7-GFP strain (Supplemental Figure 1); this enzyme of the ergosterol biosynthetic pathway is 
transported or escorted in LDs by Erg27p, which performs a chaperon function in addition to the reductase 
activity [46]. Indeed, in yeast, sterol biosynthesis the 3-keto reductase protein (Erg27p) is required for 
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oxidosqualene cyclase (Erg7p) activity [47-48]. In absence of mitochondrial DNA, the Erg7p enzyme is cor-
rectly associated with LDs and not delocalized. 
The relocalization of Erg27p in ER, following a block of mitochondrial function, is specific, since the other 
two enzymes, mainly found in LDs (Erg6p and Erg7p), are not moved to ER. 
3.3 Ergosterol content is lower in rho° cells compared with the isogenic wild-type strain 
To investigate if the Erg27p location in ER could alter the biosynthetic ergosterol pathway, we measured the 
ergosterol content in a wild type and a rho° strains by gas chromatography-mass spectrometry. The quantifi-
cation was performed in W303, the W303 rho° strain and in ∆mdm34 (rho° cells). Results reported in Figure 
4 revealed that in rho° cells the ergosterol content was significantly lower compared with the wild type iso-
genic strain. We did not investigate further ∆mdm34 strain or ERMES as responsible of the Erg27p delocali-
zation because the alteration of the ergosterol content was due to the lack of mtDNA/lack of respiration and 
not primarily to the absence of ERMES function. 
This finding suggests that, in absence of functional mitochondria, the biosynthetic ergosterol pathway is al-
tered resulting in lower ergosterol content in the cells. 
 
Figure 4. Ergosterol is in lower amount in the rho° strain and in ∆mdm34, if compared with wild-type iso-
genic strain. Gas chromatography-mass spectrometry analysis was performed to measure the ergosterol ar-
ea/internal standard area. Data are the average of 3 independent experiments and standard deviation is indi-
cated. The asterisks indicate significant modulation (* p<0.05) (** p<0.01) according to Student’s T-test. 
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3.4 Erg27p maintained its functionality when it is relocalized in ER 
To verify if the relocalization of Erg27p in ER occurring in rho° cells impair the functionality of the enzyme, 
pulse labeling experiments were performed. These experiments are designed to determine the relative 
amounts of post-squalene intermediates of ergosterol biosynthesis, not the absolute amount/content of 
ergosterol in the cells. Wild type and rho° cells in two different genetic contexts (W303 and BY4741) were 
incubated with radioactive acetate during a 3 h pulse period at 30°C. Following the pulse, nonsaponifiable 
lipids were extracted and separated on TLC plates along with authentic standards of squalene, 
oxidosqualene, dioxidosqualene, ketosteroid 1 (a mixture of 4-methylzymosterone and 4-methylfecosterone), 
ketosteroid 2 (a mixture of zymosterone and episterone, with the same Rf of dioxidosqualene), lanosterol and 
ergosterol (as a reference for 4-desmethylsterols). In wild type strains, no substantial accumulation of 
ketosteroids 1 and 2, which are direct substrates of Erg27p occurred in rho° conditions (Table 1), suggesting 
that, when Erg27p is relocalised in ER, the enzymatic activity is still present; this is confirmed by the fact 
that the dga1/lro1/are1/are2 quadruple mutant, lacking LDs, still retains ergosterol production [44]. 
The observed general increase of % incorporation of all precursors of ergosterol, tested in rho° condition, 
suggests, although does not prove, a decrease in the kinetics of ergosterol biosynthesis. 
3.5 The Retrograde pathway controls the ERG27 expression in rho° cells 
The block of the mitochondrial respiratory chain by antimycin A induces the activation of the Retrograde 
Pathway [49, 50], responsible for the modulation of nuclear transcription following a mitochondrial dysfunc-
tion. To verify if there was a modulation of ERG27 gene transcription, we measured expression by real time 
RT-qPCR quantification of ERG27 mRNA in cells with altered mitochondrial function, compared with the 
isogenic wild type strain. We analyzed also a strain unable to activate the Retrograde Pathway, ∆rtg2 [51]. 
The RT-qPCR analysis showed that ERG27 transcription was significantly induced in rho° cells (Figure 5) 
and this activation was dependent on the Retrograde Pathway because no modulation of ERG27 mRNA was 
observed in ∆rtg2 cells. As a control, we analyzed ERG11 mRNA which showed no modulation in the ab-
sence of mitochondrial DNA or following treatment with antimycin A. 
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Figure 5. The Retrograde Pathway mediates the activation of ERG27 transcription in the rho° strain. The 
ERG27 transcription is induced in rho° strain and after antimycin treatment, while the level of ERG11 re-
mains unchanged. The histograms report the ratios between the mRNA of ERG11 and ERG27 in W303 rho°, 
in ∆rtg2 and in W303 treated with antimycin. The wild type W303 untreated strain was set as 1. Data are the 
average of 4 independent experiments and standard deviation is indicated. The asterisks indicate significant 
modulations (*P<0.05) according to Student’s T-test. 
 
We then verified by Western Blot analysis the amount of Erg27p in rho° cells; compared with the wild type 
yeast cells, and we observed that the Erg27p is present in higher amount. The antimycin treatment also re-
sults in an increase of the Erg27p (Figure 6).  
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Figure 6. The Erg27p is in higher amount in rho° strain and in wild type strain after antimycin (10µg/ml) 
treatment. Western Blot analysis of W303 wild type strain, W303 rho° and W303 wild type strain treated 
with antimycin for 5, 10 and 15 minutes; the absence of mitochondrial DNA or antimycin treatment resulted 
in higher amount of Erg27p. Erg27p-GFP volume ratio bands with Image Lab 5.1 version software by Bio 
Rad: W303-ERG27-GFP 1,5934; W303-ERG27-GFP rho° 4,9201; W303-ERG27-GFP +5’ antimycin 
4,9482; W303-ERG27-GFP +10’ antimycin 2,0313; W303-ERG27-GFP +15’ antimycin 2,3670 of the re-
spective ADA2 bands. 
 
Taken together these results showed that the lack of mitochondrial function stimulates the transcription and 
translation of ERG27, that this protein is localized in ER, where it is still active (its substrate doesn’t accu-
mulate), but in this condition, the ergosterol is synthesized in lower amount in the cells (see Discussion). 
3.6 Ketoconazole, but not nystatin, induces loss of mitochondrial DNA 
The results obtained pointed to an influence of the mitochondrial status on the biosynthetic ergosterol path-
way, we then asked if, vice versa, a perturbation of the ergosterol biosynthetic pathway could affect the mi-
tochondrial function. We used ketoconazole and nystatin, molecules with a different mechanism of action, to 
monitor the percentage of petites production in yeast (i.e. yeast cells unable to growth on respiratory sub-
strate like glycerol, as the only carbon source). Ketoconazole, specifically inhibits the lanosterol 14-alpha 
demethylase enzyme (Erg11p); nystatin binds to ergosterol in the fungal membrane and it was chosen as a 
control because it doesn’t affect the ergosterol biosynthesis pathway. Figure 7 shows the percentage 
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of petites production in wild type cells treated with increasing doses of ketoconazole and nystatin, followed 
for 24, 48 and 72 hours (Figure 7A and B, respectively). Ketoconazole significantly induces petites produc-
tion at the concentration of 50μg/ml. These petites were rho° cells, i.e. devoid of mitochondrial DNA, as it 
was assessed by DAPI staining (Figure 7C). On the contrary, nystatin, at the concentration of 1μg/ml, result-
ed in a petites production of 53,38%, 30,97% and 16,33%, at 24 hours, 48 and 72 hours, respectively (Figure 
7B), (see Discussion). Vitality of the strains presented in Figure 7 is reported in Supplemental Figure 2. The-
se results suggest that a specific block of the ergosterol biosynthetic pathway induces a loss of mitochondrial 
DNA.  
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Figure 7. Percentage of petites production after treatment with nystatin and ketoconazole. A: ketoconazole 
treatment, which block ergosterol synthesis, induced a high rate of petites phenotype, due to the loss of mito-
chondrial DNA at the concentration of 50µg/ml. B: nystatin, which block ergosterol inserted in the plasma 
membrane, didn’t show a significant alteration of mitochondrial DNA maintenance at the concentrations ac-
tive in yeast. C: DAPI staining of cells presented in Figure A and B; wild type W303, W303 rho° and wild 
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type W303 treated with 50µg/ml of ketoconazole or 2g/ml of nystatin (at 72 hours) are presented. Bar: 
0.2µm. The magnification is the same in each picture. 
 
3.7 Ergosterol suppresses the rho° production of ∆erg27 strain  
If the reduction or a block of the ergosterol biosynthetic pathway induces loss of mitochondrial DNA, we 
reasoned that also the deletion of ERG27 should induce a petites phenotype and that the addition of 
ergosterol should suppress this phenotype. In S. cerevisiae, the ERG27 is essential since its absence causes a 
complete block of ergosterol synthesis, but the ∆erg27 strain associated with upc2-1 mutation is able to grow 
in a medium supplemented with the minimal requirement of 0.02mg/ml of ergosterol. Upc2p is a general 
regulator of the expression of ERG genes [52-54] and the upc2-1 mutation also increases the potency of the 
activation domain [55]. Since we cannot exclude an involvement of upc2-1 mutation in the ∆erg27 pheno-
types, as a control, we also measured the percentage of petites in a ∆erg27 strain transformed with the 
ERG27 wild type gene (strain called ∆erg27+pST10(ERG27)). We cultured the ∆erg27 strain in YPD medi-
um supplemented with 0.02 and 0.5mg/ml of ergosterol and we counted the petites production after 24 and 
48 hours of growth. Figure 8A shows that after 24 hours, the ∆erg27 strain produced 45.01% of petites, 
compared with 2.86% of petites in the W303 wild type strain. After 48 hours, i.e. stationary phase, in the 
mutant supplemented with 0.02mg/ml ergosterol, the petites percentage raised to 80.76%, while the presence 
of 0.5mg/ml of ergosterol suppressed the petites production in the ∆erg27 (20.32% of petites production), 
stabilizing the mitochondrial DNA. The ∆erg27+pST10(ERG27) doesn’t show a petites phenotype, demon-
strating that upc2-1 mutation is not involved in the ∆erg27 petites phenotype. 
These experiments showed that the absence of the ergosterol synthesis results in loss of mitochondrial DNA 
and that the external addition of ergosterol in higher amount (0.5mg/ml) than the minimal requirement 
(0.02mg/ml) to grow, is sufficient to maintain/stabilize the mitochondrial DNA. Figure 8B shows that the 
0.5mg/ml of ergosterol in YPD medium suppressed the petites production in ∆erg27 and that ergosterol is 
also able to suppress formation of petites production in ∆mdm34 strain.  
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Figure 8. Ergosterol is essential for mitochondrial DNA maintenance. A: 0.02mg/ml of ergosterol are suffi-
cient to promote ∆erg27 growth but not to maintain mitochondrial DNA, while 0.5mg/ml of ergosterol in the 
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medium suppresses the percentage of petites production of ∆erg27 strain. In presence of ergosterol in the 
medium, the ∆erg27 strain shows 45.01% and 50.48% of petites at 24 hours in YPD medium supplemented 
with 0.02 or 0.5mg/ml of ergosterol, respectively. At 48 hours, while with 0.02mg/ml of ergosterol, the min-
imal concentration required for growth, the ∆erg27 strain accumulates petites (80.76%), at the concentration 
of 0.5mg/ml ergosterol stabilizes the mtDNA (20.33% of petites). The ∆erg27+pST10(ERG27), containing 
the upc2-1 mutation in a wild type ERG27 genetic context, doesn’t show a petites phenotype. B: Ergosterol 
also suppresses the petites production of ∆mdm34 cells (from 85% to 31%). In YPD, the histogram corre-
sponding to ∆erg27 is not present because this strain doesn’t grow without ergosterol. Data are the average 
of 5 independent experiments and standard deviation is indicated.  
3.8 Mitochondrial morphology in rho° cells  
The intimate connection between mitochondrial morphology and mitochondrial DNA maintenance has been 
deeply investigated [56], so we finally visualized the mitochondrial morphology of the ∆erg27 strain trans-
forming the cells with the pVT100UGFP plasmid, containing the mitochondria-targeted GFP (mitoGFP) 
gene [31]. Indeed, an altered mitochondrial phenotype was already observed for other genes of the ergosterol 
biosynthetic pathway using a regulatable promoter [29]. Figure 9A shows that yeast cells devoid of mito-
chondrial DNA (W303 rho°) contained disorganized mitochondria in YPD medium. The lack of the ERG27 
also resulted in an aberrant mitochondrial morphology: mitochondria are clearly fragmented and round simi-
lar to that of the cells without the ERMES complex (∆mdm34 cells). In the ∆erg27 strain, the presence of the 
minimal concentration of ergosterol, (0.02mg/ml) required for growth, was not able to suppress the aberrant 
mitochondrial morphology; indeed, low concentration of ergosterol (0.02mg/ml) also didn’t suppress the loss 
of mitochondrial DNA (Figure 8). We then looked at the mitochondrial morphology at the same conditions 
in which mitochondrial DNA is maintained in ∆erg27 strain, i.e. YPD medium supplemented with 0.5mg/ml; 
in this growth condition, we observed a correct elongated mitochondrial morphology (Figure 9A) and, of 
note, this was observed also for the W303 rho° and ∆mdm34 cells. Figure 9B shows the percentage of aber-
rant round mitochondrial morphology in exponential phase with different ergosterol concentrations. Taken 
together these results demonstrated the essential function of ergosterol in maintaining a correct mitochondri-
al morphology in yeast cells.  
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Figure 9. Ergosterol is essential for the maintenance of tubular mitochondrial morphology. A: mitochondrial 
morphology visualized with mito-GFP. The W303 wild type strain shows normal branched tubular mito-
chondria, while the rho° strain contains disorganized mitochondria. ∆erg27 and ∆mdm34 share the same mi-
tochondrial phenotype, round collapsed mitochondria, this phenotype is suppressed by the addition of 
ergosterol in YPD medium. Bar: 2µm. The magnification is the same in each picture. B: Percentage of aber-
rant/round mitochondrial morphology of the strains described in A. The tubular and collapsed mitochondria 
were counted from pictures taken to produce Figure 9A; the histogram was obtained from the average of 3 
distinct biological experiments, for each experiment mitochondrial morphology phenotypes were counted 
from 100 cells. ∆erg27 strain shows 100% of collapsed round mitochondria when grow in YPD+ 0.02mg/ml 
of ergosterol, the minimal concentration required for growth. In YPD, without ergosterol addition, ∆erg27 
doesn’t grow. When ∆erg27 is supplemented with 0.5mg/ml of ergosterol, the % of cells with aberrant mito-
chondria drops to 67.52%. 0.5mg/ml of ergosterol suppresses also the mitochondrial morphology defect of 
the wild type rho° (from 83.40% to 41.50%) and ∆mdm34 cells (from 92.18% to 62.29%).  
 
4. Discussion 
In yeast, ergosterol function in mitochondrial biogenesis has not been extensively studied, nevertheless its 
presence in higher amount in the IMM compared with the OMM should has a biological significance [9, 10, 
12]. Previous observations suggest an involvement of the ERMES complex in ergosterol import since the ab-
sence of ERMES proteins altered the level of ergosterol in the cells [27]. Unfortunately, the balance between 
different class of lipids is highly regulated, rendering difficult to define if other complexes or proteins are in-
volved in ergosterol import into the mitochondria. 
Here, we showed that there is an interplay between the mitochondrial function and the ergosterol biosynthet-
ic pathway, a cross talk resulting in a modulation of ergosterol content in cells with impaired mitochondrial 
function but also an induced loss of mitochondrial DNA and an altered mitochondrial morphology when the 
ergosterol biosynthetic pathway is blocked.  
4.1 Mitochondrial dysfunction regulates ergosterol production 
To demonstrate that Erg27p could be a “sensor” of mitochondrial dysfunction, we investigated two condi-
tions in which the respiration is impaired: a) in a rho° context, i.e. cell lacking mtDNA and b) with a block of 
respiratory chain with antimycin A. 
a) We found that in rho° cells the Retrograde Pathway activates the transcription of ERG27, that the new 
synthesized enzyme is found in ER and not in LDs as in wild type cells, and this localization results in an al-
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teration of  ergosterol levels in the cells. At our knowledge, this is the first observation that the Retrograde 
Pathway regulates the ERG27. We have not further investigated the transcription of other ERG genes in ab-
sence of mitochondrial function at this stage, except for ERG11 chosen because its product is not localized in 
LDs. Indeed, ERG11 showed no modulation in the absence of mitochondrial DNA or following treatment 
with antimycin A, neither in the wild type, nor in the rtg2 strain, but this issue deserves more interest in the 
future. In rho° cells, the ergosterol content is lower as compared with the wild type strain. Our experiments 
demonstrate that the lower amount of ergosterol content in absence of Mdm34p (an ERMES complex subu-
nit) is primarily due to mtDNA absence/lack of respiration and not to the impaired ERMES function in 
transporting this sterol into the mitochondria. Indeed, the ergosterol content in strains deleted for ERMES 
complex was previously investigated, but not in a strain deleted for MDM34 [27]. 
b) The block of respiratory chain with antimycin A in wild type cells promoted a rapid migration of the 
preexisting Erg27p from LDs to ER. The observation that, if the respiratory chain is blocked by antimycin A, 
Erg27p is rapidly relocalised in ER from LDs, also indicates that the ER localization observed in rho° cells is 
not an artifact. Moreover, this is not the first described case of relocalization of an enzyme of the ergosterol 
biosynthetic pathway: Erg1p, with a dual localisation in the ER and LDs, was found to be redistributed from 
LDs to ER in low iron condition in the cells [57]. Moreover, the rapid movement of the Erg27p from LDs to 
ER in presence of antimycin A, in a few minutes, suggested the persistence of an intimate contact between 
these two organelles, supporting the hypothesis that the at least a subset of LDs remain physically connected 
with the ER [51, 56-62]. 
This part of our results suggests that, following the absence of respiration (caused by the lack of mtDNA or 
antimycin A treatment), Erg27p relocalizes in ER and that the newly synthesized Erg27p remains in ER and 
it is not targeted to LDs, resulting in a negative modulation of ergosterol production. It’s worth noting that 
the ER and plasma membrane are tethered for at least 40% of the plasma membrane [63], raising the ques-
tion if the presence of Erg27p in the cortical ER could facilitate and supply the ergosterol in plasma mem-
brane in a condition (mitochondrial dysfunction) in which the ergosterol availability is low. Future experi-
ments will address the point of how the movement of Erg27p enzyme selectively results in low ergosterol 
content in the cells. Concerning the movement of Erg27p, it is known that, in yeast, the Erg27p belongs to 
the C-4 demethylase protein complex which includes, besides Erg27p, the enzymes Erg25p (C-4 methyl oxi-
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dase), Erg26p (C-4 decarboxylase, C-3 dehydrogenase), and the scaffold protein Erg28p [64], a key protein 
in the yeast sterol biosynthetic enzyme complex [65]. The Erg25-26-27-28p complex formation, however, 
does not appear an absolute requirement to/for Erg27p activity, as the enzyme can maintain its functionality 
as a free protein (O.B.S. and G.B., manuscript in preparation). This implies that the protein can move freely 
in cytoplasmic compartments without alter its function. Nevertheless, additional experiments will be needed 
to identify the signal which promotes the selective localization of Erg27p in ER, since Erg6p and Erg7p, 
both localized in LDs in a wild type strain, are not relocalized in ER in presence of mitochondrial dysfunc-
tion. It will be interesting to verify if an imbalance of NADP+, the Erg27p cofactor, could be implicated in 
the signaling or if protein modifications such as ubiquitination or phosphorylation are involved in Erg27p 
regulation. 
Alternatively, the ergosterol content itself could be the signal for Erg27p translocation, since at least two 
other examples were published: the first example is the deletion of the SPF1 gene, which causes a 
mistargeting of the tail-anchored mitochondrial proteins in the ER instead of in the outer mitochondrial 
membrane. This is due exclusively to low ergosterol content in the cells, suggesting that lipid composition 
between organelle membranes are sufficient to determine membrane integration specificity [66]; the second 
example is that, in human cells, lowering cholesterol or inhibiting de novo synthesis of ceramides at the ER 
causes translocation of Sig-1R receptor from the mitochondria-associated ER membranes (MAMs) to ER 
cisternae [67, 68].  
Our results and recent literature point to the concept that some lipid enzymes dynamically concentrate in 
functionally defined ER regions and that can be relocalized following lipid needs [69]; an example is the tri-
acylglycerol biosynthetic pathway which relocalize from ER to growing LDs [70]. 
4.2 Block of ergosterol biosynthetic pathway causes the loss of mtDNA 
We investigated the mitochondrial DNA stability in two conditions in which the ergosterol biosynthetic 
pathway is impaired: a) specific block of ergosterol production with ketoconazole and b) a deletion of 
ERG27 gene. 
a) Ketoconazole is an antimycotic which specifically block the Erg11p function; at the concentration of 
50μg/ml, after 72 hours of treatment, the percentage of petites production was 94.86% and these petites 
were rho° cells, i.e. yeast cells devoid of mtDNA. As a control, we treated cells with nystatin: this com-
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pound binds ergosterol in the plasma membrane, promoting pore formation and it doesn’t act directly on 
the ergosterol biosynthetic pathway; nystatin, at the concentration of 1μg/ml, resulted in a petites produc-
tion of 53,38%, 30,97% and 16,33%, at 24 hours, 48 and 72 hours, respectively. The petites production in 
exponential phase (24 hours) could be explained as an indirect effect of nystatin: binding to ergosterol 
and altering the cellular membrane permeability, nystatin causes a potassium ion leakage [71]. This could 
indirectly perturb the mitochondrial K+ homeostasis [72], which has been described to alter mitochondri-
al respiration in mammalian cells [73]. In yeast, alteration of mitochondrial ion homeostasis could result 
in a limited petites production, especially in exponential phase, when cells are in active duplication. Of 
note, the vitality is always comparable to wild type at 24, 48 and 72 hours of growth (supplementary fig-
ure 2). Altogether, these results showed the essential and specific function of ergosterol in mtDNA 
maintenance. 
b) Deletion of ERG27. The ∆erg27 strain showed high petites production and ergosterol supply in the medi-
um suppressed the loss of mtDNA. The enzymes of the ergosterol biosynthetic pathway, including the 
Erg 25-26-27p complex, are essential for growing in a non-supplemented medium, (see Figure 1) but 
yeast cells can growth when ergosterol is added to the medium in presence of the upc2-1 mutation, be-
cause this allele allows for aerobic sterol uptake [30, 74-76]. We verified the minimal concentration 
(0.02mg/ml) necessary for cell survival in a strain lacking ERG27 and we measured petites production in 
this condition: after 48 hours, 80.76% of cells were petites lacking mtDNA, but with the concentration of 
0.5mg/ml of ergosterol in the medium, the same strain showed 20.32% of rho° cells, indicating that the 
supplementation of ergosterol, alone, could suppress the petites production phenotype. These results 
demonstrated, in a second independent way, the essential function of ergosterol in maintaining mtDNA. 
An emerging mechanism to distribute mtDNA throughout the mitochondrial network is suggested by the 
proximity between mtDNA nucleoids and the sites of mitochondrial fission events observed both in budding 
yeast and mammalian cells (70–80% of division events occur near nucleoids) [77-79]. So, despite the 
proteins involved in ER-mitochondria tether are not conserved in evolution, these contact sites are essential 
for coupling the mitochondrial DNA replication and mitochondrial division, both in yeast and human cells 
[78, 80-83]. 
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Indeed, cholesterol was demonstrated to be essential for human mitochondrial DNA maintenance [84]. The 
attachment of mitochondrial DNA to the IMM is related to lipid raft, membrane microdomains enriched in 
cholesterol and sphingolipids [85]. Although lipid rafts were initially thought to reside solely in the plasma 
membrane [86], increasing evidence suggests the presence of raft-like regions in internal organelles and in 
proteomic analysis of lipid raft enriched membrane, performed in human cells, also mitochondrial proteins 
were selected [87]. The structural determinants of proteins which perform their function in lipid raft has also 
been analyzed [88]; new methods and innovative techniques will permit to study these lipid rafts in the fu-
ture [89]. 
4.3 Mitochondrial morphology in rho° cells 
Previous studies reported that mutations or lower transcription of ergosterol genes resulted in abnormal mi-
tochondrial morphology: instead of tubular structures, mitochondrial are collapsed and/or fragmented, sug-
gesting the need of correct ergosterol level for maintaining the wild type tubular mitochondrial morphology 
[29]. We demonstrated that in the ∆erg27 strain the mitochondrial morphology is similar to that of the 
∆mdm34 strain, in which mitochondria have a round, collapsed shape. The ∆erg27 severe mitochondrial 
morphology phenotype is suppressed by adding ergosterol in the medium, revealing the essential function of 
ergosterol in maintaining the mitochondrial shape, in addition to mitochondrial DNA maintenance. Moreo-
ver, also the partial suppression of the ∆mdm34 mitochondrial phenotype by ergosterol underlines the fun-
damental function of the ERMES complex in mitochondrial lipid homeostasis [27]. The wild type rho° cells, 
which contain less ergosterol, show aberrant mitochondrial morphology, again indicating the relation be-
tween the lack of mitochondrial DNA, which results in the absence of respiration and oxidative phosphoryla-
tion, and mitochondrial shape [82]. 
In conclusion, we have discovered an interplay between mitochondrial physiology and ergosterol production. 
The involvement of ergosterol in maintaining mitochondrial morphology and mitochondrial DNA is of ex-
treme biological significance also because the fragmentation of mitochondrial structure and instability of 
mtDNA are strictly related to human diseases and apoptosis [90-93]. 
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Table 1. [
14
C] acetate incorporation into the non-saponifiable lipid fraction of S. cerevisiae strains. 
Strain 
 
% total radioactivity incorporated 
 
Squalene 
 
Oxido 
squalene 
 
 
Dioxido 
Squalene/ 
Ketosteroid 2 
b
 
 
Ketosteroid 1 
a
 
 
Lanosterol 
 
4-
desmethylsterols 
 
BY4741 
 
 
18.6 
 
0.4 
 
0.5 
 
0.6 
 
1.6 
 
78.3 
 
BY4741 rho° 
 
 
21.2 
 
1.6 
 
4.9 
 
4.1 
 
6.2 
 
62.0 
 
W303 
 
 
15.6 
 
0.8 
 
1.1 
 
0.9 
 
2.1 
 
79.5 
 
W303 rho° 
 
 
27.9 
 
1.1 
 
3.3 
 
1.9 
 
2.1 
 
63.7 
 
a
 ketosteroid 1 is a mixture of 4-methylzymosterone and 4-methylfecosterone. [76] 
b
 ketosteroid 2 is a mixture of zymosterone and episterone.[76]  
Values are the means of three separate experiments, each one carried out in duplicate. The maximum devia-
tions from the mean were less than 10%. 
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Supplemental Figures 
Supplemental Figure 1. Erg7p-GFP is correctly localized in LDs in wild type and its corresponding 
rho° strain. Bar: 0.5μm. In both W303 and BY4741 context, the rho° cells show the Erg27p-GFP de-
localization. 
W303-ERG27-GFP W303-ERG27-GFP rho°
BY-ERG27-GFP BY-ERG27-GFP rho°
BY-ERG7-GFP BY-ERG7-GFP rho°
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Supplemental Figure 2. Vitality of the strains presented in Figure 7A and 7B. Data are the average of 5 inde-
pendent experiments and standard deviation is indicated.  
The strains were inoculated in YPD rich medium and after 24 hours of treatment with nystatin and ketocona-
zole at different concentrations, cells were counted and 100 cells were plated on YPD plates; after growth, 
we counted 100 colonies, which correspond to 100% of vitality (24h). The same experiment was performed 
after 48, 72 and 96 hours, to obtain vitality data. 
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